Sonendo, Inc. Overview
Industry: Medical Devices
Sector: Healthcare
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. Sonendo, Inc. was incorporated in 2006 and is headquartered in Laguna Hills, California. Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic space Read MoreReported Results
What the company reported, with filing details kept small.
Quarterly result summary
Revenue was $8M (reported). Net income/share was $0.99. Net loss was -$7,536.
Revenue
$8M
reported
Net income/share
$0.99
reported
Net loss
-$7,536
reported
Adjusted EBITDA
-$5.1M
-54% YoY
What changed
- Revenue reported to $8M.
- Adjusted EBITDA -54% YoY to -$5.1M.
Guidance / outlook
No formal outlook was extracted from this filing excerpt. Open the SEC source to review full management commentary.
Earnings release
Open filing
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Other recent earnings materials
SEC filing
10-K
Mar 26, 2025
SEC filing
10-Q
Nov 12, 2024
SEC filing
8-K
Nov 12, 2024
SEC filing
8-K
Oct 10, 2024
Earnings release
Earnings release
Oct 10, 2024
SEC filing
10-Q
Aug 07, 2024
SEC filing
8-K
Aug 07, 2024
Earnings release
Earnings release
Aug 07, 2024
SEC filing
10-Q
May 08, 2024
SEC filing
8-K
May 08, 2024
Earnings release
Earnings release
May 08, 2024
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
No qualified company news in the last 14 days
No recent article passed both the company-relevance and source-reliability checks. Research continues to use the other available filings, fundamentals, market data, and valuation inputs.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Verified SEC statements load when this section enters view.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.